Technology

BioMarin Announces Global Settlement with Ascendis Pharma A/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Brazil and South Korea

August 31, 2026 pr newswire nynewscast
BioMarin Announces Global Settlement with Ascendis Pharma A/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Brazil and South Korea

Agreement Resolves all Pending Patent-Related Proceedings Between BioMarin and Ascendis SAN RAFAEL, Calif., Aug. 30, 2026 /PRNewswire/ — BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that it has entered into...

Read Full Article

This article was originally published on nynewscast. Click the button above to read the complete article.

Related Articles

Vancouver’s SenseNet buys wildfire division of N5 Sensors

Vancouver’s SenseNet buys wildfire division of N5 Sensors
Nigeria’s Payment Revolution Enters Its Next Chapter as FoPCC 2026 Looks “Beyond the Horizon”

Nigeria’s Payment Revolution Enters Its Next Chapter as FoPCC 2026 Looks “Beyond the Horizon”

AVANTE ANNOUNCES FIRST QUARTER FISCAL 2027 RESULTS: ACHIEVES REVENUE OF $10 MILLION WITH 128% INCREASE IN ADJUSTED EBITDA
Going Down the AI Music Slop Chute with Camilo Landau

Going Down the AI Music Slop Chute with Camilo Landau
KuCoin Launches KuLeague With 400,000 USDT Reward Pool and Dynamic Team Rematching

KuCoin Launches KuLeague With 400,000 USDT Reward Pool and Dynamic Team Rematching
The Trump Administration’s Plan for Protecting Consumers? Politely Ask Companies to Behave.

The Trump Administration’s Plan for Protecting Consumers? Politely Ask Companies to Behave.